Arcutis Biotherapeutics
ARQT
ARQT
102 hedge funds and large institutions have $1.19B invested in Arcutis Biotherapeutics in 2021 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 40 increasing their positions, 25 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
9% more funds holding
Funds holding: 94 → 102 (+8)
2.95% less ownership
Funds ownership: 93.51% → 90.57% (-2.9%)
12% less capital invested
Capital invested by funds: $1.35B → $1.19B (-$160M)
Holders
102
Holding in Top 10
5
Calls
$4.36M
Puts
$698K
Top Buyers
| 1 | +$12.5M | |
| 2 | +$7.33M | |
| 3 | +$6.17M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$5.03M |
| 5 |
ACM
Altium Capital Management
New York
|
+$3.2M |
Top Sellers
| 1 | -$57.5M | |
| 2 | -$8.48M | |
| 3 | -$4.21M | |
| 4 |
MS
Maven Securities
St Helier,
Jersey
|
-$3.29M |
| 5 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$3.28M |